David T. Zhu

726 total citations
44 papers, 376 citations indexed

About

David T. Zhu is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Health. According to data from OpenAlex, David T. Zhu has authored 44 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Public Health, Environmental and Occupational Health, 10 papers in Epidemiology and 9 papers in Health. Recurrent topics in David T. Zhu's work include Opioid Use Disorder Treatment (12 papers), Vaccine Coverage and Hesitancy (8 papers) and SARS-CoV-2 and COVID-19 Research (7 papers). David T. Zhu is often cited by papers focused on Opioid Use Disorder Treatment (12 papers), Vaccine Coverage and Hesitancy (8 papers) and SARS-CoV-2 and COVID-19 Research (7 papers). David T. Zhu collaborates with scholars based in United States, Canada and Sweden. David T. Zhu's co-authors include Claire Kendall, Andrea S. Gershon, Tetyana Kendzerska, Rébecca Robillard, Jodi D. Edwards, Cayden Peixoto, Kumanan Wilson, Suzanne Tamang, Philippe Bourgois and Fernando Montero and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

David T. Zhu

37 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David T. Zhu United States 10 83 82 72 66 58 44 376
Jessica Hanae Zafra‐Tanaka Peru 12 27 0.3× 70 0.9× 75 1.0× 66 1.0× 22 0.4× 59 430
Matteo Bolcato Italy 11 23 0.3× 68 0.8× 75 1.0× 56 0.8× 52 0.9× 41 400
Lucas Marinacci United States 9 57 0.7× 92 1.1× 145 2.0× 70 1.1× 45 0.8× 27 441
Fatemeh Shahbazi Iran 11 28 0.3× 102 1.2× 32 0.4× 60 0.9× 48 0.8× 55 330
Leah Kirumbi Kenya 10 90 1.1× 44 0.5× 100 1.4× 185 2.8× 70 1.2× 15 540
Oluwabunmi Ogungbe United States 13 20 0.2× 80 1.0× 80 1.1× 87 1.3× 45 0.8× 61 418
Casey Tak United States 14 58 0.7× 214 2.6× 106 1.5× 81 1.2× 40 0.7× 63 523
Tonia C. Onyeka Nigeria 12 96 1.2× 168 2.0× 106 1.5× 69 1.0× 57 1.0× 58 459
Katrien Vanthomme Belgium 11 118 1.4× 159 1.9× 107 1.5× 63 1.0× 68 1.2× 47 471
Hannah L. Brooks Canada 11 17 0.2× 71 0.9× 103 1.4× 86 1.3× 33 0.6× 27 400

Countries citing papers authored by David T. Zhu

Since Specialization
Citations

This map shows the geographic impact of David T. Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David T. Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David T. Zhu more than expected).

Fields of papers citing papers by David T. Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David T. Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David T. Zhu. The network helps show where David T. Zhu may publish in the future.

Co-authorship network of co-authors of David T. Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of David T. Zhu. A scholar is included among the top collaborators of David T. Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David T. Zhu. David T. Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, David T. & Joseph J. Palamar. (2025). Responding to medetomidine: clinical and public health needs. The Lancet Regional Health - Americas. 44. 101053–101053. 4 indexed citations
2.
Zhu, David T., Joseph Friedman, Suzanne Tamang, & Joseph P. Gone. (2025). Drug overdose mortality rates among non-Hispanic American Indian/Alaska Native individuals, 1999–2022. Annals of Epidemiology. 105. 80–88.
3.
Zhu, David T. & Manuel Cano. (2025). Fentanyl-xylazine overdose deaths in the USA, 2018–2023. Injury Prevention. ip–2024. 3 indexed citations
5.
Zhu, David T., et al.. (2024). US Cancer Mortality Trends Among Asian and Pacific Islander Populations. JAMA Network Open. 7(11). e2442451–e2442451. 3 indexed citations
6.
Zhu, David T., et al.. (2024). Public health and clinical implications of Dobbs v. Jackson for patients and healthcare providers: A scoping review. PLoS ONE. 19(3). e0288947–e0288947. 10 indexed citations
7.
Zhu, David T., et al.. (2024). Supervised safe consumption sites — lessons and opportunities for North America. The Lancet Regional Health - Americas. 39. 100889–100889. 2 indexed citations
8.
Zhu, David T., et al.. (2024). Disparities in Cancer Mortality among Disaggregated Asian American Subpopulations, 2018–2021. Journal of Racial and Ethnic Health Disparities. 12(4). 2473–2495. 4 indexed citations
9.
Zhu, David T.. (2024). Structural racism: a fundamental cause of drug overdose disparities. The Lancet Regional Health - Americas. 38. 100875–100875. 3 indexed citations
10.
Zhu, David T., et al.. (2024). Disaggregating Asian-American Mortality in Drug-Related Overdoses and Behavioral Disorders: A Cross-Sectional Study. Journal of Racial and Ethnic Health Disparities. 12(3). 1508–1516. 3 indexed citations
11.
Zhu, David T., Devon Greyson, Sarah E. Wilson, et al.. (2024). A scoping review of active, participant centred, digital adverse events following immunization (AEFI) surveillance of WHO approved COVID-19 vaccines: A Canadian immunization Research Network study. Human Vaccines & Immunotherapeutics. 20(1). 2293550–2293550. 2 indexed citations
12.
Zhu, David T., Tanu Gupta, & Rafael Pérez‐Escamilla. (2024). Empowering Global Health Systems to Protect, Promote and Support Optimal Breastfeeding. Maternal and Child Nutrition. 21(1). e13753–e13753. 2 indexed citations
13.
Zhu, David T., et al.. (2023). The barriers, facilitators and association of vaccine certificates on COVID-19 vaccine uptake: a scoping review. Globalization and Health. 19(1). 73–73. 4 indexed citations
14.
Zhu, David T., Suzanne Tamang, & Keith Humphreys. (2023). Promises and perils of the FDA's over-the-counter naloxone reclassification. The Lancet Regional Health - Americas. 23. 100518–100518. 6 indexed citations
15.
Bettinger, Julie A., Katherine Atkinson, Cameron Bell, et al.. (2023). Comparing the Use of a Mobile App and a Web-Based Notification Platform for Surveillance of Adverse Events Following Influenza Immunization: Randomized Controlled Trial. JMIR Public Health and Surveillance. 9. e39700–e39700. 3 indexed citations
16.
Kendzerska, Tetyana, David T. Zhu, Michael Pugliese, et al.. (2023). Trends in outpatient and inpatient visits for separate ambulatory-care-sensitive conditions during the first year of the COVID-19 pandemic: a province-based study. Frontiers in Public Health. 11. 1251020–1251020. 1 indexed citations
17.
Zhu, David T.. (2023). Cross-sectoral community and civic engagement after Dobbs v. Jackson. The Lancet Regional Health - Americas. 22. 100514–100514. 2 indexed citations
18.
Zhu, David T., et al.. (2023). The Global Impact of Vaccine Certificates on COVID-19 Vaccine Uptake: A Scoping Review. Research Square. 2 indexed citations
19.
Zhu, David T., et al.. (2021). A scoping review of global vaccine certificate solutions for COVID-19. Human Vaccines & Immunotherapeutics. 18(1). 1–12. 26 indexed citations
20.
Kendzerska, Tetyana, David T. Zhu, Andrea S. Gershon, et al.. (2021). The Effects of the Health System Response to the COVID-19 Pandemic on Chronic Disease Management: A Narrative Review. Risk Management and Healthcare Policy. Volume 14. 575–584. 146 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026